Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Balance Sheets

v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 29, 2025
Dec. 28, 2024
Current assets    
Cash and cash equivalents $ 140.8 $ 149.3
Accounts receivable, less allowance for credit losses of $15.1 and $18.1, as of March 29, 2025 and December 28, 2024, respectively 120.6 136.5
Contract assets 28.2 23.2
Inventories 53.3 53.3
Prepaid expenses 7.5 7.2
Other current assets 10.9 16.0
Total current assets 361.3 385.5
Property, plant, and equipment, net 61.1 56.8
Right-of-use assets, net 59.1 59.7
Intangible assets, net 365.7 373.5
Goodwill 383.4 383.1
Deferred tax assets, net 36.0 36.9
Other assets 5.2 5.8
Total assets 1,271.8 1,301.3
Current liabilities    
Accounts payable 57.8 53.9
Contract liabilities 17.9 17.9
Current maturities of long-term debt 7.5 8.8
Accrued expenses and other current liabilities 56.1 56.2
Total current liabilities 139.3 136.8
Long-term debt, net 544.5 583.2
Deferred tax liabilities, net 1.7 1.7
Other long-term liabilities 59.5 60.8
Total liabilities 745.0 782.5
STOCKHOLDERS’ EQUITY    
Common stock, 825,000,000 shares authorized, $0.0001 par value, 148,164,578 and 147,280,524 shares issued as of March 29, 2025 and December 28, 2024, respectively 0.0 0.0
Treasury stock, at cost, 8,230,011 and 7,276,549 shares as of March 29, 2025 and December 28, 2024, respectively (89.1) (81.4)
Additional paid-in capital 303.7 299.7
Accumulated other comprehensive loss (2.9) (3.8)
Retained earnings 315.1 304.3
Total stockholders’ equity 526.8 518.8
Total liabilities and stockholders’ equity $ 1,271.8 $ 1,301.3